View more job listings or post a job
BioMarin Associate Director / Sr. Scientist for Clinical Pharmacology
Simulations Plus, Inc. Sr. PBPK Modeler – Competitive pay, full-time employment, travel opportunities
Takeda Senior Scientist- DMPK
Johnson & Johnson Senior Medical Director, Clinical Research
Johnson & Johnson Senior Medical Director - Neurovascular Senior Research Associate - DMPK
Revolution Medicines Senior Scientist, Drug Metabolism and Pharmacokinetics   
Merck & Co. Postdoctoral Research Fellow – High Content Imaging
Nuventra Pharma Sciences Senior Consultant, Clinical Pharmacology / Pharmacokinetics / Pharmacometrics
Charles River Laboratories Scientific Director, Laboratory Sciences
Post a job


Immunogenicity of Biologic Therapeutics

Speakers: Soumi Gupta, Anu Cherukuri, Lynne Jesaitis, Andrew Melton, Kevin Larimore, Brian Long (Biomarin); Shan Chung, Valerie Quamby, Montserrat Carrasco-Triguero, Eric Wakshull (Genentech)
Date: 10/11/2017
Time: 8:45-17:00
Registration fee (USD): Regular: $195; Academic: $125; Students & Unemployed: $35;
Location: Crowne Plaza, Foster City, CA
Major Sponsor: (1)Medpace
Vendor show vendors registered to date: (14)AIT Bioscience; Aragen Bioscience, Inc.; CMIC, Inc.; Eurofins; Immudex; Intertek; inVentiv Health Clinical; JOINN Labs; MicroConstants; Pacific BioLabs; PPD; Precision for Medicine; Science Exchange; WuXi AppTec
Registration deadline:10/10/2017  (it will close sooner if the seating cap is reached)

About the Topic

Biotechnology-derived (biologics) therapeutics including  monoclonal antibodies, proteins, peptides, and enzymes have provided patients with targeted and effective medicines for numerous diseases. All therapeutic proteins have the potential to generate immune responses or immunogenicity through the anti-drug antibody (ADA) formation or cell based immune responses.  The challenge for industry is to understand the factors contributing to and predicting immunogenicity, to design assays to measure and monitor the immune response, and find improved methods of administering the biologic therapeutics to minimize any negative impact. 

This symposium will discuss challenges imposed by new FDA guidances and bioanalytical strategies for measuring clinical immunogenicity, tools for immunogenicity prediction, strategies for minimizing immunogenicity in the clinic and integrated data analysis plans.


8:45 – 10:15 am: Overview of immunogenicity of Biologic Therapeutics (Soumi Gupta, Anu Cherukuri)

10:20 – 10:50 am: Strategies for Bioanalytical Analysis to Enable Clinical Immunogenicity Assessment and Addressing new FDA Immunogenicity Assay Guidance – Challenges and Approaches (Andrew Melton)
10:55 – 11:10 am: Break
11:10 – 11:20 am: Major Sponsor's presentation (Medpace)
11:30 am – 12: 00 pm: Tools for immunogenicity prediction (Shan Chung)
12:00 – 1:00 pm: Lunch
1:05 – 1:35 pm: Risk-Based Approach for Assessment of Impurities (Valerie Quamby)
1:40 – 2:10 pm: Fit for Purpose NAb Assay Development (Kevin Larimore)
2:10 – 2:40 pm: Immune Tolerance (Brian Long)
2:40 - 2:55 pm: Break
3:00 – 3:30 pm: Immunogenicity of ADC and multi-domain characterization (Montserrat Carrasco-Triguero)
3:40 – 4:10 pm: Integrated Clinical Data Analysis (Eric Wakshull)
4:10 – 4:30 pm: Panel Discussion

2018-04-24, Regulatory Authority Inspection Preparation and Outcomes
2018-04-27, SOT-PBSS Joint Spring Symposium: Immuno-oncology: Opportunities, Therapeutic Approaches, and Safety Considerations
2018-05-22, Understanding and Overcoming High Clearance and Poor Bioavailability: Fundamentals, Investigations and Strategies for Drug Discovery
©Pharmaceutical & BioScience Society, International; Last Modified: 3/24/2018; Visited: 467; Admin Logon
Ads (in random order)
Submit a Text Ad
($200 for 2 months)

Clinverse Inc. A global technology company solely focused on automating the financial management of clinical trials.
Simulations Plus The new ADMET Predictor™ 8.1 provides #1-rated ADME-Tox predictions with improved performance for large libraries. Request an evaluation today!
Simulations Plus GastroPlus™ developers launch PKPlus™. Generate validated PK reports for regulatory submissions. Value pricing/licensing. Request an evaluation today.
Pharm-Olam International Pharm-Olam is a midsize CRO offering a wide range of Phase I-IV comprehensive, clinical research services to the pharma, biotech & device industries.
Reaction Biology Corporation (RBC) RBC provides kinase & epigenetic assays and proteins for early-stage programs. Contact:
Simulations Plus Are you ready to integrate in silico modeling & simulation to augment your research activities, but don’t have the time or resources? We can help!
MicroConstants MicroConstants is a GLP-compliant Contract Research Organization focused on performing regulated bioanalysis, drug metabolism and PK analysis.
Charles River 2nd Annual Viral Summit The 2-day summit unites industry experts in an interactive setting to share updates and discuss trends in viral safety and viral clearance.
Hypha Discovery Specialists in provision of drug metabolites at mg-g scale, including CYP/Non-CYP metabolites and conjugates such as glucuronides/sulfates.
Pharmaron Our Vision: To become the world-leading small-molecule life science R&D service company, supporting our partners from discovery to commercialization
Avecia Pharma Services Nitto Avecia Pharma provides GMP contract development and parenteral manufacturing services to the pharma/biotech industries. Visit our Irvine labs!
Nektar Therapeutics Sr. Scientist - Bioanalytical Contributes to the development, validation, and implementation of ligand-binding assays. PhD and 5 years exp.
INTERTEK PHARMACEUTICAL SERVICES Intertek, a bioanalytical CRO (drugs, biologics, proteins, ADCs, biosimilar, generics, peptide, biomarker, immunogenicity, ADA, Nab) in San Diego CA
Pacific BioLabs Offers toxicology,microbiology,analytical and bioanalytical services with a combination of technical expertise & rigorous quality systems.
Nuventra Pharma Sciences With a background in clinical pharmacology and PK/PD, Nuventra enables our clients to make better strategic decisions.
Sirius Analytical Services and Automated Instruments for pKa, log P/D, solubility, dissolution. New Scissor instrument for sub-cutaneous injection site simulation.
Simulations Plus GastroPlus™ PBPK modeling workshops scheduled around the globe to train scientists on the new guidance documents from the FDA and EMA. Register today!
S-Matrix Fusion QbD® Software – Analytical Method Development & Validation, Formulation & Process R&D. Works with ChemStation, Chromeleon, and Empower.
PHARMA INVENTOR Vancouver based Canadian Custom Synthesis Services Company, Offers Inventive & Cost-Effective Chemical Synthesis Services to Life Sciences Industries.
Zef Scientific California’s premier multi-vendor LC-MS/MS engineering firm with highest level of services & rapid onsite response on all major brands & models.
Solid Form Solutions Ltd Solid Form Solutions Ltd CRO providing Solid State Crystallization and Analytical Testing Services to the pharma/biotech industries.
Protein Characterization Seminar hosted by Charles River Join us in San Diego on September 15, 2017 to discuss the analytical methods used to detect process residuals and determine biosimilarity.
Submit a Text Ad